Find Reports

Select Report Type

Reimbursement Review

Displaying 651 - 675 of 1422

Please scroll or swipe to the right to view the full content.

Title	Brand Name	Generic Name	Files	Therapeutic Area	Recommendation Type	Status	Submission Date	Recommendation Date Sort ascending	Project Number
Rotigotine	Neupro	Rotigotine	cdr_SR0432_Neupro_Resubmission.pdf SR0432_complete_Neupro_Resb_Nov-24-15_e.pdf SR0432_Neupro_CL_Report_resub.pdf SR0432_Neupro_PE_Report_resub.pdf SR0432_Neupro_PI_Submissions.pdf	Parkinson’s disease	List with clinical criteria and/or conditions	Complete	May 21, 2015	Nov 19, 2015	SR0432-000
Ivermectin	Rosiver	Ivermectin	SR0429 Rosiver.pdf SR0429_complete_Rosiver_Nov-23-15_e.pdf SR0429_Rosiver_CL_Report.pdf SR0429_Rosiver_PE_Report.pdf SR0429 Rosiver_PI_Submissions_Consolidated_validated.pdf	Rosacea	List with criteria/condition	Complete	Apr 30, 2015	Nov 19, 2015	SR0429-000
Keytruda for Metastatic Melano...	Keytruda	Pembrolizumab	pcodr_provfund_pembrolizumab_keytruda_mm.pdf pcodr_pembrolizumab_keytruda_mm_fn_rec.pdf pcodr_pembrolizumab_keytruda_mm_fn_cgr.pdf pcodr_pembrolizumab_keytruda_mm_fn_egr.pdf pcodr_pembrolizumab_keytruda_mm_in_rec.pdf pcodr_pembrolizumab_keytruda_mm_pagfdk.pdf pcodr_pembrolizumab_keytruda_mm_fdk-merck.pdf pcodr_pembrolizumab_keytruda_mm_ptfdk_sysf.pdf pcodr_pembrolizumab_keytruda_mm_ptfdk_mnc.pdf pcodr_pembrolizumab_keytruda_mm_coi_sysf.pdf pcodr_pembrolizumab_keytruda_mm_coi_mnc.pdf pcodr_pembrolizumab_keytruda_mm_coi_cspa.pdf	Metastatic Melanoma	Reimburse with clinical criteria and/or conditions	Complete	Apr 16, 2015	Nov 16, 2015	PC0058-000
Cyramza for Advanced GC or GEJ...	Cyramza	Ramucirumab	pcodr_profund_ramucirumab_cyramza_gc.pdf pcodr_ramucirumab_cyramza_gc_fn_rec.pdf pcodr_ramucirumab_cyramza_gc_fn_cgr.pdf pcodr_ramucirumab_cyramza_gc_fn_egr.pdf pcodr_ramucirumab_cyramza_gc_in_rec.pdf pcodr_ramucirumab_cyramza_gc-pagfdk.pdf pcodr_ramucirumab_cyramza_gc-fdk-elc.pdf	Metastatic Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma	Reimburse with clinical criteria and/or conditions	Complete	Apr 15, 2015	Oct 29, 2015	PC0059-000
Secukinumab	Cosentyx	Secukinumab	TS0001-PsO-Updated-Streamlined-Rec.pdf cdr_SR0407_Cosentyx.pdf SR0407_Cosentyx_Oct-30-15.pdf SR0407_Cosentyx_CL_Report.pdf SR0407_Cosentyx_PE_Report.pdf SR0407_Cosentyx_PI_Submissions.pdf	Plaque psoriasis	List with criteria/condition	Complete	Dec 8, 2014	Oct 28, 2015	SR0407-000
Vedolizumab	Entyvio	Vedolizumab	cdr_SR0421_Entyvio.pdf SR0421_cdr_complete_Entyvio_Nov-2-15_e.pdf SR0421_Entyvio_CL_Report.pdf SR0421_Entyvio_PE_Report.pdf SR0421_Entyvio_PI_Submissions.pdf	Ulcerative colitis	List with clinical criteria and/or conditions	Complete	Feb 20, 2015	Oct 28, 2015	SR0421-000
Taliglucerase alfa	Elelyso	Taliglucerase alfa	cdr_SR0390_Elelyso.pdf SR0390_Elelyso_Oct-30-15.pdf SR0390_Elelyso_CL_Report.pdf SR0390_Elelyso_PE_Report.pdf	Gaucher disease	Do not list	Complete	Aug 15, 2014	Oct 28, 2015	SR0390-000
Empagliflozin	Jardiance	Empagliflozin	Recommendation and Reasons: Updated Submission Status Report Recommendation and Reasons: Original Clinical Report Pharmacoeconomic Report Patient Group Input Submissions	Diabetes mellitus, type 2	List with clinical criteria and/or conditions	Complete	Apr 23, 2015	Oct 15, 2015	SR0427-000
Nintedanib	Ofev	Nintedanib	cdr_SR0426_Ofev.pdf SR0426_Ofev_Oct-19-15.pdf SR0426_Ofev_CL_Report.pdf SR0426_Ofev_PE_Report.pdf SR0426_Ofev_PI_Submissions.pdf	Idiopathic pulmonary fibrosis	List with clinical criteria and/or conditions	Complete	Apr 23, 2015	Oct 15, 2015	SR0426-000
Iclusig for Chronic Myeloid Le...	Iclusig	Ponatinib	pcodr_provfund_iclusig_cml-all.pdf pcodr_ponatinib_iclusig_cml-all_fn_rec.pdf pcodr_ponatinib_iclusig_cml-all_fn_cgr.pdf pcodr_ponatinib_iclusig_cml-all_fn_egr.pdf pcodr_ponatinib_iclusig_cml_all_in_rec.pdf pcodr_ponatinib_iclusig_cml-all_pagfdk.pdf pcodr_ponatinib_iclusig_cml-all_fdk_ariad.pdf	Chronic Myeloid Leukemia/ Acute Lymphoblastic Leukemia	Reimburse with clinical criteria and/or conditions	Complete	Mar 13, 2015	Oct 1, 2015	PC0056 -000
Linaclotide	Constella	Linaclotide	cdr_SR0409_Constella.pdf SR0409_Constella_ Sept_25-15.pdf SR0409_Constella_CL_Report.pdf SR0409_Constella_PE_Report.pdf SR0409_Constella_PI_Submissions.pdf	Irritable bowel syndrome with constipation	Do not list	Complete	Dec 17, 2014	Sep 23, 2015	SR0409-000
Daclatasvir	Daklinza	Daclatasvir	cdr_SR0417_Daklinza.pdf SR0417_cdr_complete_Daklinza_Sept-23-15_e.pdf SR0417_Daklinza_CL_Report.pdf SR0417_Daklinza_PE_Report.pdf SR0417 Daklinza_PI_Submissions.pdf	Hepatitis C, Chronic	List with clinical criteria and/or conditions	Complete	Feb 13, 2015	Sep 21, 2015	SR0417-000
Denosumab (Drug Plan Submissio...	Prolia	Denosumab (Drug Plan Submission)	cdr_SR0414_Prolia-Men.pdf SR0414_cdr_complete_Prolia-Men_Sept-21-15-e.pdf SR0414_ProliaMen_CL_Report.pdf SR0414_ProliaMen_PE_Report.pdf SR0414_ProliaMen_PI_Submissions.pdf	Osteoporosis, men	List with clinical criteria and/or conditions	Complete	Mar 10, 2015	Sep 21, 2015	SR0414-000
Umeclidinium	Incruse Ellipta	Umeclidinium	cdr_SR0422_Incruse-Ellipta.pdf SR0422_Incruse_Ellipta_Sept-22-15.pdf SR0422_Incruse_Ellipta_CL_Report.pdf SR0422_Incruse_Ellipta_PE_Report.pdf	Chronic obstructive pulmonary disease	List with criteria/condition	Complete	Mar 4, 2015	Sep 18, 2015	SR0422-000
Aclidinium bromide/formoterol ...	Duaklir Genuair	Aclidinium bromide/formoterol fumarate dihydrate	cdr_SR0423_Duaklir_Genuair.pdf SR0423_Duaklir_Genuair_Sept-22-15-e.pdf SR0423_DuaklirGenuair_PI.pdf SR0423_DuaklirGenuair_FDC_Report.pdf	Chronic obstructive pulmonary disease	List with clinical criteria and/or conditions	Complete	Apr 1, 2015	Sep 18, 2015	SR0423-000
Zydelig for Chronic Lymphocyti...	Zydelig	Idelalisib	pcodr-provfund_idelalisib-zydelig-cll.pdf pcodr_idelalisib_zydelig_cll_fn_rec.pdf pcodr_idelalisib_zydelig_cll_fn_cgr.pdf pcodr_idelalisib_zydelig_cll_fn_egr.pdf Idelalisib Initial Recommendation_ 2015-07-30_AC_30July2015_FinalPost.pdf pcodr_idelalisib_zydelig_cll_pagfdk.pdf pcodr_idelalisib_zydelig_cll_API.pdf pcodr_idelalisib_zydelig_cll_ptfdk_lc.pdf pcodr_idelalisib_zydelig_cll_coi_lc.pdf pcodr_idelalisib_zydelig_cll_ptfdk_cllpag_llsc.pdf pcodr_idelalisib_zydelig_cll_coi_cllpag.pdf pcodr_idelalisib_zydelig_cll_coi_llsc.pdf	Chronic lymphocytic leukemia	Reimburse with clinical criteria and/or conditions	Complete	Apr 7, 2015	Aug 18, 2015	PC0057-000
Apremilast	Otezla	Apremilast	cdr_SR0400_Otezla.pdf SR0400-Otezla-Aug-10-15-e.pdf SR0400_Otezla_CL_Report.pdf SR0400_Otezla_PE_Report.pdf	Plaque psoriasis	Do not list	Complete	Oct 8, 2014	Jul 22, 2015	SR0400-000
Avastin (with capecitabine) fo...	Avastin (with capecitabine)	Bevacizumab	pcodr_provfund_avastin-capecitabine_mcrc.pdf pcodr_avastin_capecitabine_mcrc_fn_rec.pdf pcodr_avastin_capecitabine_mcrc_fn_cgr.pdf pcodr_avastin_capecitabine_mcrc_fn_egr.pdf pcodr_avastin_capecitabine_mcrc_in_rec.pdf pcodr_avastin_capecitabine_mcrc_pagfdk.pdf pcodr_avastin_capecitabine_mcrc_fdk_roche.pdf pcodr_avastin_capecitabine_mcrc_ptfdk_ccac.pdf pcodr_avastin_capecitabine_mcrc_coi_ccac.pdf	Metastatic Colorectal Cancer	Reimburse with clinical criteria and/or conditions	Complete	Feb 18, 2015	Jul 21, 2015	PC0055-000
Xalkori Resubmission for First...	Xalkori	Crizotinib	pcodr-provfund_xalkori_nsclc1stline.pdf pcodr_xalkori_1stln_nsclc_fn_rec.pdf pcodr_xalkori_1stln_nsclc_fn_cgr.pdf pcodr_xalkori_1stln_nsclc_fn_egr.pdf pcodr_xalkori_1stln_nsclc_in_rec.pdf pcodr_xalkori_1stln_nsclc_pagfdk.pdf pcodr_xalkori_1stln_nsclc_fdk_pfizer.pdf pcodr_xalkori_1stln_nsclc_coi_ola.pdf pcodr_xalkori_1stln_nsclc_coi_lcc.pdf	First Line ALK Positive Advanced NSCLC	Reimburse with clinical criteria and/or conditions	Complete	Feb 17, 2015	Jul 21, 2015	PC0054-000
Tafinlar & Mekinist in com...	Tafinlar & Mekinist in combo	Dabrafenib & Trametinib in combo	pcodr-provfund_tafinlarmekinist_melanoma.pdf pcodr_tafinlar_mekinist_metmelanoma_fn_rec.pdf pcodr_tafinlar_mekinist_metmelanoma_fn_cgr.pdf pcodr_tafinlar_mekinist_metmelanoma_fn_egr.pdf pcodr_tafinlar_mekinist_metmelanoma_in_rec.pdf pcodr_tafinlar_mekinist_metmelanoma_pagfdk.pdf pcodr_tafinlar_mekinist_metmelanoma_fdk_gsm.pdf pcodr_tafinlar_mekinist_metmelanoma_ptfdk_mnc.pdf pcodr_tafinlar_mekinist_metmelanoma_ptfdk_sysf.pdf pcodr_tafinlar_mekinist_metmelanoma_coi_mnc.pdf pcodr_tafinlar_mekinist_metmelanoma_coi_sysf.pdf	Metastatic Melanoma	Reimburse with clinical criteria and/or conditions	Complete	Feb 13, 2015	Jul 21, 2015	PC0053-000
Tiotropium bromide	Spiriva Respimat	Tiotropium bromide	SR0412 Spiriva Respimat.pdf SR0412-complete-Spiriva-Respimat-July-20-15-e.pdf SR0412_SpirivaRespimat_CL_Report.pdf SR0412_SpirivaRespimat_PE_Report.pdf SR0412_SpirivaRespimat_PI_Submissions.pdf	Chronic obstructive pulmonary disease	List with clinical criteria and/or conditions	Complete	Dec 23, 2014	Jul 16, 2015	SR0412-000
Nexavar for Metastatic Progres...	Nexavar	Sorafenib	pcodr-provfund_sorafenib_nexavar_dtc.pdf pcodr_sorafenib_nexavar_dtc_fn_rec.pdf pcodr_sorafenib_nexavar_dtc_fn_cgr.pdf pcodr_sorafenib_nexavar_dtc_fn_egr.pdf pcodr_sorafenib_nexavar_dtc_in_rec.pdf pcodr_sorafenib_nexavar_dtc_pagfdk.pdf pcodr_sorafenib_nexavar_dtc_fdk_bayer.pdf pcodr_sorafenib_nexavar_dtc_ptfdk_tcc.pdf pcodr_sorafenib_nexavar_dtc_coi_tcc.pdf	Metastatic Progressive Differentiated Thyroid Carcinoma (DTC)	Do not reimburse	Complete	Dec 19, 2014	Jul 16, 2015	PC0049-000
Perjeta or Perjeta-Herceptin C...	Perjeta or Perjeta-Herceptin Combo Pack	Pertuzumab	pcodr-provfund_pertuzumab_perjeta_nbc.pdf pcodr_pertuzumab_perjeta_nbc_fn_rec.pdf pcodr_pertuzumab_perjeta_nbc_fn_cgr.pdf pcodr_pertuzumab_perjeta_nbc_fn_egr.pdf pcodr_pertuzumab_perjeta_nbc_in_rec.pdf pcodr_pertuzumab_perjeta_nbc_pagfdk.pdf pcodr_pertuzumab_perjeta_nbc_fdk_roche.pdf pcodr_pertuzumab_perjeta_nbc_ptfdk_cbcn.pdf pcodr_pertuzumab_perjeta_nbc_coi_cbcn.pdf	Neoadjuvant Breast Cancer	Do not reimburse	Complete	Dec 19, 2014	Jul 16, 2015	PC0050-000
Stivarga Resubmission for mCRC...	Stivarga Resubmission (CRC)	Regorafenib	pcodr-provfund_regorafenib_stivarga-resub_mcrc.pdf pcodr_regorafenib_stivarga_resub_mcrc_fn_rec.pdf pcodr_regorafenib_stivarga_resub_mcrc_fn_cgr.pdf pcodr_regorafenib_stivarga_resub_mcrc_fn_egr.pdf pcodr_regorafenib_stivarga_resub_mcrc_in_rec.pdf pcodr_regorafenib_stivarga_resub_mcrc_pagfdk.pdf pcodr_regorafenib_stivarga_resub_mcrc_fdk_bayer.pdf pcodr_regorafenib_stivarga_resub_mcrc_ptfdk_ccac.pdf pcodr_regorafenib_stivarga_resub_mcrc_coi_ccac.pdf	Metastatic Colorectal Cancer	Do not reimburse	Complete	Dec 19, 2014	Jul 16, 2015	PC0046-000
Proleukin for In-transit Melan...	Proleukin	Aldesleukin (IL-2)	pcodr-provfund_proleukin-melanoma.pdf pcodr_aldesleukin_proleukin_fn_rec.pdf pcodr_adesleukin_proleukin_fn_cgr.pdf pcodr_adesleukin_proleukin_fn_egr.pdf pcodr-aldesleukin-proleukin-in-transit-melanoma-in-rec.pdf pcodr_adesleukin_proleukin_pagfdk_0.pdf pcodr_adesleukin_proleukin_fdk_novartis.pdf pcodr_adesleukin_proleukin_ptfdk_mnc.pdf pcodr_adesleukin_proleukin_coi_mnc.pdf pcodr_adesleukin_proleukin_coi_sysf.pdf	In-transit Melanoma	Reimburse	Complete	Jan 30, 2015	Jun 22, 2015	PC0051-000

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 576 - 600 of 600

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 110 of 110

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 27 of 27

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 651 - 675 of 2132

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Project Sub Line	Status	Project Number
deferiprone	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Apr 27, 2023	Reimbursement Review		Complete	SR0741-000
berotralstat	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Apr 27, 2023	Reimbursement Review		Complete	SR0723-000
Occupational Therapy for Mental Health Conditions and Substance Use Disorders	RC1478 OT and Mental Health.pdf	Apr 27, 2023	Health Technology Review	Rapid Review	Completed	RC1478-000
Risk of Sexual Transmission of HIV With Antiretroviral Therapy and Variable or Suppressed Viral Load	Risk of Sexual Transmission of HIV With Antiretroviral Therapy and Variable or …	Apr 25, 2023	Health Technology Review	Technology Review	Completed	HC0050-000
pembrolizumab	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Apr 25, 2023	Reimbursement Review		Complete	PC0280-000
lumasiran	Recommendation and Reasons Clinical, Pharmacoeconomic and Ethics combined Report Stakeholder feedback on Draft Recommendation	Apr 25, 2023	Reimbursement Review		Complete	SR0734-000
anifrolumab	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Apr 24, 2023	Reimbursement Review		Complete	SR0717-000
Alternative Therapies to Immunoglobulin for Multifocal Motor Neuropathy	Alternative Therapies to Immunoglobulin for Multifocal Motor Neuropathy	Apr 21, 2023	Health Technology Review	Rapid Review	Completed	RC1479-000
Considerations of Access and Inclusion in Adolescent Eating Disorder Care: A Custom Rapid Report	Considerations of Access and Inclusion in Adolescent Eating Disorder Care: A Cu…	Apr 20, 2023	Health Technology Review	Technology Review	Completed	HC0043-000
Reducing the Environmental Impact of Clinical Care	Reducing the Environmental Impact of Clinical Care	Apr 20, 2023	Horizon Scan		Completed	EH0112-000
CADTH Pharmaceutical Reviews Update — Issue 36		Apr 20, 2023	Reimbursement Review	Pharmaceutical Review Update
brolucizumab	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Apr 19, 2023	Reimbursement Review		Complete	SR0747-000
lemborexant	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Apr 19, 2023	Reimbursement Review		Complete	SR0716-000
dupilumab	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Apr 18, 2023	Reimbursement Review		Complete	SR0745-000
lurbinectedin	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Apr 18, 2023	Reimbursement Review		Complete	PC0281-000
dupilumab	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Apr 13, 2023	Reimbursement Review		Complete	SF0754-000
Laser Treatment for Lower Back Pain	Laser Treatment for Lower Back Pain	Apr 12, 2023	Horizon Scan	Health Technology Update	Completed	EN0044-000
Large B-Cell Lymphoma	Final Report	Apr 11, 2023	Reimbursement Review	Provisional Funding Algorithm	Completed	PH0027-000
belimumab	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Apr 10, 2023	Reimbursement Review		Complete	SR0746-000
CADTH Pharmaceutical Reviews Update — Issue 35		Mar 30, 2023	Reimbursement Review	Pharmaceutical Review Update
Formulary Management of Biologics in Plaque Psoriasis	Formulary Management of Biologics in Plaque Psoriasis	Mar 24, 2023	Health Technology Review	Technology Review	Completed	HD0011-000
Living With Type 2 Diabetes	Living With Type 2 Diabetes	Mar 24, 2023	Health Technology Review	Technology Review	Completed	HC0045-000
Tocilizumab for Neuromyelitis Optica Spectrum Disorder	Tocilizumab for Neuromyelitis Optica Spectrum Disorder	Mar 24, 2023	Health Technology Review	Rapid Review	Completed	RC1477-000
Canakinumab for Adult-Onset Still Disease	Canakinumab for Adult-Onset Still Disease	Mar 22, 2023	Health Technology Review	Rapid Review	Completed	RC1475-000
ferumoxytol		Mar 20, 2023	Reimbursement Review		Withdrawn	SR0753-000